Hypothesis: NAD+ elevation alone is insufficient to extend lifespan; it must be coupled with a transient rise in mitochondrial ROS to activate sirtuin-mediated stress defenses. In other words, NAD+ serves as a permissive cofactor that enables ROS‑sensitive sirtuins to shift cells into a protective state, whereas NAD+ supplementation without ROS signaling fails to engage the longevity program.

Rationale: Hormetic interventions such as caloric restriction, exercise, and mild heat shock increase both NAD+ levels and mitochondrial ROS production (https://pmc.ncbi.nlm.nih.gov/articles/PMC3742177/). The ROS act as signaling molecules, not as damage, because antioxidants abolish the lifespan benefits of caloric restriction (https://pmc.ncbi.nlm.nih.gov/articles/PMC3742177/). NAD+ fuels sirtuin deacetylase activity, but sirtuins also require redox‑sensitive activation—oxidation of regulatory cysteines enhances their affinity for NAD+ (https://www.aging-us.com/article/100411/text). Thus, the NAD+/ROS duo functions as a coincidence detector: only when both are elevated do sirtuins fully activate downstream effectors like FOXO/DAF-16, leading to autophagy, HSP expression, and improved proteostasis (https://pmc.ncbi.nlm.nih.gov/articles/PMC3578457/).

Predictions: 1) In Caenorhabditis elegans, treatment with an NAD+ precursor (e.g., nicotinamide riboside) alone will raise NAD+ but not extend mean lifespan. 2) Combining the same NAD+ precursor with a mild, sub‑toxic mitochondrial ROS generator (e.g., low-dose paraquat or menadione) will synergistically increase lifespan by >20% relative to control. 3) Genetic inhibition of sir-2.1 (the worm SIRT1 ortholog) will abolish the lifespan extension seen with the NAD+ + ROS combination, confirming sirtuin dependence. 4) Measuring DAF-16 nuclear translocation and autophagy flux (lgG‑1::GFP) will show significant increases only in the combined treatment group.

Falsifiability: If NAD+ supplementation alone reproducibly extends lifespan in worms under standard laboratory conditions, or if the NAD+ + ROS combination fails to outperform NAD+ alone, the hypothesis is refuted. Similarly, if sir-2.1 loss does not diminish the benefit of the combined treatment, the proposed sirtuin‑centric mechanism is invalid.

Extension: This model reframes hormesis not as a generic stress response but as a precise metabolic coincidence detection system that couples energy status (NAD+) with redox state (ROS) to gatekeep longevity pathways. It suggests that interventions aiming to boost NAD+ without eliciting a controlled ROS signal—such as high-dose NR supplementation in sedentary individuals—may improve metabolic health but will not activate the deep‑time survival program that underlies true lifespan extension.